Scott M. Rocklage is a Ph.D. holder from Massachusetts Institute of Technology. Besides, he is also an alumnus of the University of California, Berkeley where he earned his BS in chemistry. In 2003, Mr. Scott joined 5AM Ventures as a partner, and later in 2004 became part of the administrative crew. The heath industry recognizes him as an outstanding figure who has seen over thirty years of solid experience. In the past, he has assumed strategic offices where he pushed FDA to approve three new drug applications in the U.S.
In his tenures, he has founded and co-founded more than thirty patents in the United States, as well as published over a hundred books, which are all peer-reviewed. The Boston-based specialist is currently the chairman of Board of several organizations namely; Achaogen, Semprus, Relypsa, WaveRx, Pulmatrix and Variation. Scott’s able leadership is recognized in most states across America, particularly his excellent knowledge of his specialty.
Background Information Regarding 5AM Ventures
5AM Ventures is an enterprise comprising of professionals possessing high qualities in a broad spectrum of specialties among them being; medicine, operations, law, science as well as finance. Basically, it serves capital purposes, focusing on improving the future companies in the health sectors, especially those depicting an ability to deliver cutting-edge returns to their investors. The members, Mr. Scott being one among the partners, contribute towards achieving their success.
Previous Investments by Scott in 5AM Ventures
Following his superior knowledge in the medical fields, Mr. Scott has been up to various advisory and presidential roles. Between October 2006 and March 2013, there are several investments he made within 5AM Ventures. The investments were serial, and they include; achaogen, rennovia, pulmatrix, as well as novira therapeutics.
- Scott Rocklage is a proven, time-tested and self-made administrator possessing a vast knowledge in the health sector. Prior to joining 5AM Ventures, he had served several other significant offices relating to medicine. He had even been president and chairman of Nycomed Interventional, Inc. between 1992 and 1994. His input in the entire United States is quite notable, particularly on inventions. His far-reaching healthcare management skills are matchless.